BRIEF published on 06/03/2025 at 17:05, 1 year 4 months ago Evotec SE Annual General Meeting 2025 Highlights Drug Discovery Shareholder Decisions Strategic Outlook Evotec 2025 AGM Board Introductions
PRESS RELEASE published on 06/03/2025 at 17:00, 1 year 4 months ago Evotec SE: Results of the Annual General Meeting 2025 Evotec SE shareholders approve proposals at Annual General Meeting 2025, featuring strategic outlook and new Management Board members; 46.45% share capital represented Annual General Meeting Shareholders Evotec SE Management Board Strategic Outlook
BRIEF published on 05/07/2025 at 07:35, 1 year 4 months ago Evotec obtient une subvention de 2,5 millions de dollars pour le développement d'un traitement contre la tuberculose Evotec Santé Mondiale Résistance Aux Médicaments Tuberculose Fondation Gates
BRIEF published on 05/07/2025 at 07:35, 1 year 4 months ago Evotec Secures $2.5 Million Grant for Tuberculosis Treatment Development Evotec Global Health Drug Resistance Tuberculosis Gates Foundation
PRESS RELEASE published on 05/07/2025 at 07:30, 1 year 4 months ago Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE receives $2.5 m grant from Gates Foundation to develop next-generation tuberculosis treatments, focusing on drug combinations to reduce treatment duration and overcome resistance Evotec SE Grant Gates Foundation Tuberculosis Treatments Drug Combinations
BRIEF published on 05/06/2025 at 07:05, 1 year 4 months ago Evotec SE publie ses résultats financiers du premier trimestre 2025 dans un contexte de marché faible Partenariats Stratégiques Perspectives Financières Croissance Des Produits Biologiques Evotec T1 2025 Dégradation Des Protéines
BRIEF published on 05/06/2025 at 07:05, 1 year 4 months ago Evotec SE Reports Q1 2025 Financial Results Amid Soft Market Strategic Partnerships Financial Outlook Biologics Growth Protein Degradation Evotec Q1 2025
PRESS RELEASE published on 05/06/2025 at 07:00, 1 year 4 months ago Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE reports Q1 2025 results, highlighting strategic partnerships & sustainable growth plans in soft market. 2025 guidance and 2028 outlook confirmed Strategic Partnerships Evotec SE Growth Plans Q1 2025 Soft Market
BRIEF published on 04/29/2025 at 10:07, 1 year 5 months ago Evotec SE to Announce Q1 2025 Results on May 6 Financial Results Conference Call Evotec SE Therapeutics Development Webcast Details
BRIEF published on 04/29/2025 at 10:07, 1 year 5 months ago Evotec SE annoncera ses résultats du premier trimestre 2025 le 6 mai Résultats Financiers Evotec SE Conférence Téléphonique Développement Thérapeutique Détails De La Webdiffusion
Published on 10/03/2026 at 02:35, 17 hours 58 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 6 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 7 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 7 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 4 hours 48 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 20 hours 38 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 1 day 1 hour ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 1 day 2 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 2 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 2 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 3 hours ago Aéroports de Paris SA - Calendrier financier 2027
